NUVB Stock Analysis: Buy, Sell, or Hold?
NUVB - Nuvation Bio Inc.
$5.30
0.06 (1.15%)
▲
5d:
-3.63%
30d:
-40.85%
90d:
+2.91%
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
30d
Get Alerted When NUVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called NUVB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NUVB shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: NUVB shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.09
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.02
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NUVB is currently trading at $5.30, which is considered oversold relative to its 30-day fair value range of $5.74 to $8.88. The stock's valuation (Forward PE: 9.5) is in line with its historical norms (10.5). Remarkably, the market is currently pricing in an annual earnings decline of 3.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NUVB is in a strong uptrend. Immediate support is located at $5.12, while resistance sits at $6.25.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.89 (+126.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NUVB is in a strong uptrend. Immediate support is located at $5.12, while resistance sits at $6.25.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.89 (+126.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.74 -
$8.88
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 126.9% below Wall St target ($11.89)
Fair Price Analysis
30-Day Fair Range
$5.74 -
$8.88
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$5.12
Resistance Level
$6.25
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
9.53
Wall Street Target
$11.89
(+126.9%)
Revenue Growth (YoY)
1704.7%
Valuation Discount vs History
-3.3% cheaper
PE vs Historical
9.5 vs 10.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.3%
(market-implied from PE analysis)
1-Year Target
$5.07
(-3%)
2-Year Target
$4.90
(-7%)
3-Year Target
$4.74
(-10%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$5.22
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.5 to 10.5
Stabilization Target:
$5.78
(+10.2%)
PE Expansion Potential:
+10.2%
Last updated: February 02, 2026 10:33 AM ET
Data refreshes hourly during market hours. Next update: 11:33 AM
Data refreshes hourly during market hours. Next update: 11:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
Advanced NUVB Option Strategies
Professional options setups generated by AI based on today's NUVB price and gamma walls.